The increases also reflected additional funds raised in stock offerings. These helped pay for new or expanded research projects, many of which necessitated hiring more staff, often at higher salaries, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Todays Five Things You Need to ...

Hookipa Pharma CEO Joern Aldag is betting on brighter days for biotech. With Hookipa’s stock stuck in the doldrums, Aldag is waiving 50% of his salary over the first half of the year in return for ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has updated employment agreements with key executive officers, including ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...